Actively Recruiting

Age: 18Years - 95Years
All Genders
ID02869529

Institut Paoli Calmettes Chronic Lymphatic Leukemia Database

Led by Institut Paoli-Calmettes · Updated on 2016-08-17

4200

Participants Needed

1

Research Sites

47 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research collects information from patients diagnosed with chronic lymphatic leukemia to create a detailed database. The goal is to study characteristics and long-term survival of these patients over a 10-year period. The study is observational, meaning researchers gather data without testing new treatments. Participants' medical information is collected and recorded as part of the study. No specific treatments or interventions are given as part of this research. The study started in 2006 and will continue gathering data through 2030. Participants will be involved through data collection of their health records and disease characteristics. Researchers will monitor survival outcomes and patient details over 10 years. There are no additional treatments or procedures required, and usual care continues with the participant’s own doctor.

CONDITIONS

Brief Title

Institut Paoli Calmettes Chronic Lymphatic Leukemia Database

Who Can Participate

Age: 18Years - 95Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of chronic lymphatic leukemia
  • Age between 18 and 95 years
Not Eligible

You will not qualify if you...

  • Matutes score less than 4

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Long-term Monitoring

Duration - Up to 10 years

Participants diagnosed with chronic lymphatic leukemia are observed over time to collect data on survival and patient characteristics.

Trial Site Locations

Total: 1 location

1

Institut Paoli-Calmettes

Marseille, Bouches-du Rhône, France, 13009

Actively Recruiting

Loading map...

Research Team

D

Dominique Genre, MD

L

Lilian Laborde

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Real-World Study of Fixed-Duration Ibrutinib plus Venetoclax...

Leukemia, Lymphocytic, Chronic, B-Cell

Actively Recruiting

1 location

A Phase 3, Open-label, Randomized Study Comparing Nemtabruti...

Leukemia, Lymphocytic, Chronic, B-Cell

Actively Recruiting

54 locations

Multicohort Study to Customize Ibrutinib Treatment Regimens ...

Leukemia, Lymphocytic, Chronic, B-Cell

Actively Recruiting

74 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here